Suppr超能文献

免疫调节剂用于破坏性肺结核患者化疗的疗效

The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.

作者信息

Khomenko A G, Insanov A B

出版信息

Z Erkr Atmungsorgane. 1986;167(1-2):163-7.

PMID:3765712
Abstract

Immunomodulators are to be prescribed to tuberculous patients in accordance with clinical and immunologic indices for 2 months. Taking into account that levamisol in dose 100 mg/24 hours is well tolerated by the patients and is as efficient as in the dose 150 mg/24 hours it is recommended to use this agent in dose 100 mg/24 hours three times a week. As it became evident from the clinical-roentgenologic, bacteriologic and immunologic data diuciphon is better tolerated by the patients and more efficient than levamisol.

摘要

应根据临床和免疫学指标为结核病患者开具免疫调节剂,疗程为2个月。考虑到患者对24小时100毫克剂量的左旋咪唑耐受性良好,且与24小时150毫克剂量的疗效相同,建议每周三次使用24小时100毫克剂量的该药物。从临床X线、细菌学和免疫学数据来看,双硫芬比左旋咪唑更易被患者耐受且疗效更佳。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验